Patients have long awaited a process whereby doctors could examine specific areas in the body without requiring invasive surgical procedures. In vivo imaging for cancer evaluation has nearly made this a reality internationally. Today, most organs and tissues can be seen in real time without causing undue stress to the patient. This process provides a closer and clearer view point that enables physicians to make a more accurate diagnosis as well as providing a live view of the area to measure the growth of diseased tissue.
This particular modality can also help physicians form a plan of treatment and determine how aggressive that treatment plan needs to be. Lesser degrees of radiation and lower doses of chemotherapy are safer alternatives which are desired for all patients. A more accurate prognosis can be made because due to live images which show the rate of disease progression.
Another way this viewing of organs and tissue helps the patient is by enabling oncologists to locate the specific area to be targeted with radiation, marginalizing the risk of damaging healthy tissue. The therapies in use can then be monitored and treatment dosage can be altered to improve the outcome. Older methods were less certain of protecting healthy tissue and were unable to accurately monitor the progress of the treatment.
In the past, sometimes painful biopsies were required and often repeated until the proper section of tissue was acquired. This new technology eliminates the need for random biopsies by isolating the area in question more accurately. It is an invaluable tool for observing precancerous situations.
Researchers and oncologists are promoting this new technique internationally via speeches and workshops covering research data. The in vivo process of bio-medical imaging can change the current standards used to diagnose, treat and evaluate malignant areas by providing safer and more precise procedures. This means less pain and more certain outcomes for many patients suffering from the effects of this disease.
Metastasis is one aspect of malignancy that needs to be understood so it can be stopped. As new techniques emerge, one hopes that they will provide new and improved methods by which doctors can analyze the growth and progression of tumors in the body. One of the ways in which imaging is advancing is by adapting the use of fluorescent lighting.
Alternative sources for agents used in targeted molecular viewing are now being developed. Researchers seek to improve the absorption of agents to speed up the process of locating problem areas which may have cancer cells, and to enable accurate formation of a diagnosis. Numerous animals have been used in the past to monitor the progress of abnormal cell growth during different stages. These new developments will reduce the amount of animal research formerly required.
Another emerging lighting agent is an enzyme extracted from fireflies, known as bio-luminescence. All of these elements provide hope for physicians and their patients that malignancies can by diagnosed and treated with minimal or no surgical incisions using in vivo imaging for cancer evaluation. So far, this dynamic solution has been used in areas such as the colon area, the abdomen and in breast tissue.
Author Resource:-
The cutting-edge digital imaging company provides modalities designed for preclinical research, such as invivo and molecular imaging. They specialize in the highest quality of biomarker, micro imaging, mouse heart, in vivo, and photoacoustic systems.
![[Valid RSS feed]](http://www.massagebyben.com/articles/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed
Print This Article
Add To Favorites 